Nxera Pharma Co Ltd (SOLTF)
8.052
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Nxera Pharma Total Assets (Quarterly): 972.39M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 972.39M |
| March 31, 2024 | 1.006B |
| December 31, 2023 | 1.115B |
| September 30, 2023 | 1.000B |
| June 30, 2023 | 718.66M |
| March 31, 2023 | 740.89M |
| December 31, 2022 | 758.25M |
| September 30, 2022 | 658.75M |
| June 30, 2022 | 667.91M |
| March 31, 2022 | 785.33M |
| December 31, 2021 | 842.80M |
| September 30, 2021 | 794.64M |
| June 30, 2021 | 735.87M |
| March 31, 2021 | 719.52M |
| December 31, 2020 | 741.40M |
| September 30, 2020 | 693.85M |
| June 30, 2020 | 474.72M |
| March 31, 2020 | 489.15M |
| December 31, 2019 | 520.49M |
| September 30, 2019 | 549.50M |
| June 30, 2019 | 541.58M |
| March 31, 2019 | 557.78M |
| September 30, 2018 | 557.71M |
| June 30, 2018 | 592.77M |
| March 31, 2018 | 653.86M |
| Date | Value |
|---|---|
| December 31, 2017 | 655.93M |
| September 30, 2017 | 487.94M |
| June 30, 2017 | 480.70M |
| March 31, 2017 | 430.09M |
| December 31, 2016 | 451.36M |
| September 30, 2016 | 474.24M |
| June 30, 2016 | 534.24M |
| March 31, 2016 | 421.31M |
| December 31, 2015 | 401.24M |
| September 30, 2015 | 353.77M |
| June 30, 2015 | 368.35M |
| March 31, 2015 | 398.50M |
| December 31, 2014 | 132.85M |
| September 30, 2014 | 137.55M |
| June 30, 2014 | 145.21M |
| March 31, 2014 | 141.70M |
| December 31, 2013 | 62.46M |
| September 30, 2013 | 70.74M |
| June 30, 2013 | 63.75M |
| March 31, 2013 | 91.50M |
| December 31, 2012 | 84.17M |
| September 30, 2012 | 91.22M |
| June 30, 2012 | 86.11M |
| March 31, 2012 | 90.21M |
| December 31, 2011 | 98.89M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
474.72M
Minimum
Jun 2020
1.115B
Maximum
Dec 2023
759.78M
Average
740.89M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 102.04B |
| PeptiDream Inc | 595.81M |
| Healios KK | 110.68M |
| AnGes Inc | 171.98M |
| SanBio Co Ltd | 23.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 543.75M |
| Shareholders Equity (Quarterly) | 428.64M |
| Debt to Equity Ratio | 0.9607 |
| Current Ratio | 4.105 |
| Net Debt Paydown Yield | 4.74% |